克洛扎治疗患者显著的血液学变化:患病率和临床相关性
Muhammed Fatih Tabara1, Cafer Baris Akar2, Mehmet Kadir Atdagi2
1Department of Psychiatry, Firat University School of Medicine, Elazig, Turkey.
Acta neuropsychiatrica
|November 21, 2024
概括
在精神分裂症中使用克洛札可以引起白细胞 (36.9%) 和血栓细胞 (8.9%). 高剂量与白细胞瘤相关,强调需要仔细监测血液和个性化剂量,以管理这些血液风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 血液学 血液学 血液学
背景情况:
- 克洛扎是治疗耐药精神分裂症的重要非典型抗精神病药物.
- 它的有效性源于广泛的受体向,包括血清素和多巴胺受体.
- 显著的血液学风险,如农细胞瘤,需要严格监测.
研究的目的:
- 在接受克洛扎的患者中调查血液学参数.
- 为了确定白细胞瘤,血栓细胞瘤和改变的RDW/MPV等异常的患病率.
- 探索克洛扎剂量/持续时间与这些血液学变化之间的临床相关性.
主要方法:
- 对157名接受克洛沙平治疗的患者的血液学数据的分析.
- 评估白细胞,血栓细胞,红细胞分布宽度 (RDW) 和平均血小板体积 (MPV).
- 克洛扎剂量,持续时间和血液学参数之间的统计相关性分析.
主要成果:
- 在36.9%的患者中观察到白细胞症.
- 在8.9%的患者中检测到血栓细胞瘤.
- 在23.6%的患者中发现RDW升高;较高的克洛扎剂量与白细胞症有关.
结论:
- 定期的血液学监测对于管理克洛扎诱导的风险至关重要.
- 个性化剂量策略可能有助于平衡克洛札的疗效和安全性.
- 了解血液学变化是优化克洛沙平治疗的关键.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Mania and Antimanic Drugs: Overview
136
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
136


